PHILADELPHIA.Today on MSN
Wistar Institute recruits Vincent Wu to join Vaccine & Immunotherapy Center as Caspar Wistar Fellow
The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious disease, is pleased ...
Arrowhead Pharmaceuticals, Inc. today announced that it has dosed the first subjects in a Phase 1/2a clinical trial of ARO-MAPT, the company's investigational RNA interference (RNAi) therapeutic being ...
A webcast of the conference call can be accessed by visiting “Investor Events” on the investor relations section of the Wave Life Sciences website: ...
Modern Engineering Marvels on MSN
Mark Kelly hails exciting Bennu discovery linking sugars to RNA origins
Could a dusty rock hurtling through space hold the recipe for life? NASA’s latest analysis of asteroid Bennu’s pristine ...
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared ...
The CDC Advisory Committee on Immunization Practices met last week, eliminating the universal recommendation for the birth dose of the hepatitis B vaccine. There was, however, a more insidious threat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback